UNIVERSITY OF NORTH CAROLINA HOSPITALS

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1989-01-01

Employees: -

Market Cap: -

Website: http://www.unc.edu/interactive-tour/unc-hospitals/

Clinical Trials

Phase II Trial of Sequential Consolidation With Pembrolizumab Followed by Nab-paclitaxel

Phase 2

Completed

Conditions: Non Small Cell Lung Cancer

Interventions: Drug: Pembrolizumab

First Posted Date: 2016-02-18

Last Posted Date: 2022-06-03

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 20

Registration Number: NCT02684461

Locations: 🇺🇸
Inova Schar Cancer Institute, Fairfax, Virginia, United States
🇺🇸
Rex Cancer Center, Raleigh, North Carolina, United States
🇺🇸
UT Southwestern Medical Center, Dallas, Texas, United States

and more 2 locations

Physical Activity to Maintain Quality of Life and Physical Function in Women With Metastatic Breast Cancer: a Pilot Study

Not Applicable

Completed

Conditions: Metastatic Breast Cancer

Interventions: Behavioral: Walk with Ease

First Posted Date: 2016-02-15

Last Posted Date: 2022-01-06

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 60

Registration Number: NCT02682836

Locations: 🇺🇸
UNC Cancer Hospital, Chapel Hill, North Carolina, United States

Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation

Completed

Conditions: Xerostomia

First Posted Date: 2016-02-15

Last Posted Date: 2019-09-23

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 100

Registration Number: NCT02682199

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina, United States

Administration of T Lymphocytes for Prevention of Relapse of Lymphomas

Phase 1

Active, not recruiting

Conditions: Lymphoproliferative Disorders
Lymphoma, Non-Hodgkin
Neoplasms
Neoplasms by Histologic Type
Lymphoma
Lymphatic Diseases
Immune System Diseases
Hodgkin Disease
Immunoproliferative Disorders

Interventions: Drug: ATLCAR.CD30 cells

First Posted Date: 2016-01-26

Last Posted Date: 2024-04-23

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 18

Registration Number: NCT02663297

Locations: 🇺🇸
Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill, North Carolina, United States

Rituximab Plus CHOP Chemotherapy for Diffuse Large B-cell Lymphoma

Phase 2

Completed

Conditions: HIV
Diffuse Large B-cell Lymphoma

Interventions: Drug: R-CHOP

First Posted Date: 2016-01-21

Last Posted Date: 2022-10-28

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 39

Registration Number: NCT02660710

Locations: 🇲🇼
UNC Project, Lighthouse Trust, Lilongwe, Malawi

Effect of Human Papillomavirus Self-Collection on Cervical Cancer Screening in High Risk Women: My Body, My Test 3

Not Applicable

Completed

Conditions: Cervical Cancer
Human Papillomavirus
Uterine Cervical Neoplasms

Interventions: Behavioral: Screening invitation (with education)
Behavioral: Self-collection for HPV testing

First Posted Date: 2016-01-11

Last Posted Date: 2022-12-02

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 665

Registration Number: NCT02651883

Locations: 🇺🇸
University of North Carolina Gillings School of Public Health, Chapel Hill, North Carolina, United States

Fitness in Allogeneic Stem Cell Transplantation

Not Applicable

Completed

Conditions: Hematopoietic Stem Cell Transplantation

Interventions: Behavioral: Interval Exercise Training/Motivational Accelerometry

First Posted Date: 2015-09-30

Last Posted Date: 2018-07-06

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 35

Registration Number: NCT02564458

Locations: 🇺🇸
Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States

Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy

Completed

Conditions: Circulating Tumor Cells

Interventions: Other: Blood draw

First Posted Date: 2015-05-20

Last Posted Date: 2022-09-28

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 162

Registration Number: NCT02449837

Locations: 🇺🇸
University of North Carolina at Chapel Hill, Department of Radiation Oncology, Chapel Hill, North Carolina, United States

Phase II Trial of Palbociclib in Patients With Metastatic Urothelial Cancer After Failure of First-Line Chemotherapy

Phase 2

Terminated

Conditions: Metastatic Urothelial Carcinoma (UC)

Interventions: Drug: Palbociclib

First Posted Date: 2015-01-08

Last Posted Date: 2018-11-16

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 12

Registration Number: NCT02334527

Locations: 🇺🇸
University of Michigan, Ann Arbor, Michigan, United States
🇺🇸
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
🇺🇸
North Carolina Cancer Hospital (UNC), Chapel Hill, North Carolina, United States

The CARE Program: CAncer REhabilitation Pilot Study for Older Adults

Not Applicable

Completed

Conditions: Cancer

Interventions: Other: Occupational and Physical Therapy

First Posted Date: 2014-12-03

Last Posted Date: 2017-09-12

Lead Sponsor: UNC Lineberger Comprehensive Cancer Center

Target Recruit Count: 67

Registration Number: NCT02306252

Locations: 🇺🇸
University of North Carolina, Chapel Hill, North Carolina, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy